Reducing Medication Use in Adults With I/DDImage Banner

Reducing Medication Use in Adults With I/DD

You are here

Reducing Medication Use in Adults With I/DD

February 18, 2014 - 6:00pm to 7:30pm
Eastern Standard Time


National Core Indicators (NCI) data and state level studies show adults with I/DD are administered psychotropic medication much more frequently than other Medicaid beneficiaries. For example, 53% of people with I/DD receiving services take medication for mood disorders, anxiety, behavior challenges and/or psychotic disorders.

In this webinar, you will learn more about the NCI findings, as well as studies in Georgia and Massachusetts. You’ll also hear what steps several states are taking to reduce over-medication in adults with I/DD, the challenges they faced and lessons learned.


  • Valerie Bradley, President, Human Services Research Institute

  • Gail Grossman, Assistant Commissioner for Quality Management, Massachusetts Department of Developmental Services

  • Emily Lauer, Center for Developmental Disabilities Evaluation and Research

  • Sue Kelly, Senior Scientist, Delmarva Foundation

  • Eddie Towson, Director of Quality Assurance, Georgia Division of Developmental Disabilities


  • ANCOR members - $65

  • Non-members - $95

  • Registration is closed.